
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 10, 2023, titled "Press Release and MDA for Second quarter and Half Year ended 30th September, 2023".
Filed with NSE ·

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 10, 2023, titled "Press Release and MDA for Second quarter and Half Year ended 30th September, 2023".
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals